Huneif Mohammed Ayed, Al Mutairi Majed, AlHazmy Ziyad Hamad, AlOsaimi Fatima Khalid, AlShoomi Anas M, AlGhofely Mohammed A, AlSaheel Abdulhameed
Pediatric Endocrinologist at at Department of Pediatrics, College of Medicine, Najran University Hospital, Najran University, Najran Saudi Arabia.
Pediatric Radiologist at the Pediatric Radiology Department, Children's Specialized Hospital, King Fahad Medical City, Riyadh, Saudi Arabia.
J Pediatr Endocrinol Metab. 2021 Nov 9;35(1):49-54. doi: 10.1515/jpem-2021-0291. Print 2022 Jan 27.
To assess the incidence of testicular adrenal rest tumors (TARTs) among male children with congenital adrenal hyperplasia (CAH) in tertiary care centers.
All male children aged 1-14 years diagnosed with CAH due to 21-hydroxylase deficiency (21 HOD), 11β-hydroxylase deficiency, and 3β-hydroxysteroid dehydrogenase deficiency, confirmed by biochemical and/or genetic testing, underwent scrotal ultrasound examination to identify TARTs. After receiving the diagnosed patients' data, patients' electronic medical records were accessed to collect demographic data and scrotal ultrasound results, along with growth parameters and specific biochemical test results within 2 months of the ultrasound.
TARTs were observed in 5 (10.9%) of 46 male children with CAH. Four patients with positive findings had 21 HOD classical CAH with salt loss and one had 21 HOD simple virilizing classical CAH. All patients had poor compliance and stage 2 bilateral TARTs. Three TART-positive patients (60.0%) had high ACTH levels, 5 patients (100%) had elevated 17-OHP levels, and 5 patients (100%) had advanced bone age. The youngest patient with positive findings was 4 years old.
The prevalence of TARTs increases with age and can be present in young males with classical CAH with 21 HOD. It is associated with elevated 17-hydroxyprogesterone (17-OHP) and advanced bone age SDS. TARTs are less likely to be associated with nonclassical CAH with 21 HOD or other less common CAHs due to 11β-hydroxylase deficiencies and 3β-hydroxysteroid dehydrogenase deficiencies in children. Our study recommends early and routine screening of TARTs in children with CAH.
评估三级医疗中心中先天性肾上腺皮质增生症(CAH)男性患儿睾丸肾上腺残余肿瘤(TARTs)的发病率。
所有年龄在1至14岁、经生化和/或基因检测确诊因21-羟化酶缺乏(21 HOD)、11β-羟化酶缺乏和3β-羟类固醇脱氢酶缺乏导致CAH的男性患儿,均接受阴囊超声检查以确定是否存在TARTs。在获取确诊患者的数据后,查阅患者的电子病历以收集人口统计学数据、阴囊超声检查结果,以及超声检查后2个月内的生长参数和特定生化检测结果。
46例CAH男性患儿中有5例(10.9%)观察到TARTs。4例检查结果呈阳性的患者患有伴有失盐的21 HOD经典型CAH,1例患有21 HOD单纯男性化经典型CAH。所有患者依从性差,均为2期双侧TARTs。3例TART阳性患者(60.0%)促肾上腺皮质激素(ACTH)水平高,5例患者(100%)17-羟孕酮(17-OHP)水平升高,5例患者(100%)骨龄超前。检查结果呈阳性的最年幼患者为4岁。
TARTs的患病率随年龄增长而增加,可出现在患有21 HOD经典型CAH的年轻男性中。它与17-羟孕酮(17-OHP)升高和骨龄标准差超前有关。儿童中,TARTs不太可能与伴有21 HOD的非经典型CAH或因11β-羟化酶缺乏和3β-羟类固醇脱氢酶缺乏导致的其他较罕见的CAH相关。我们的研究建议对CAH患儿进行早期和常规的TARTs筛查。